We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Oral drug delivery company, IntelGenx, has entered into a definitive worldwide agreement with Aquestive Therapeutics for the co-development and commercialization of Tadalafil oral films for the treatment of erectile dysfunction (ED).